Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
12.60
-0.26 (-2.02%)
Nov 20, 2024, 4:00 PM EST - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $627.09 million as of November 21, 2024. Its market cap has increased by 89.49% in one year.
Market Cap
627.09M
Enterprise Value
363.48M
1-Year Change
89.49%
Ranking
Category
Stock Price
$12.60
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $627.09M, an increase of 0.35%. That is a compound annual growth rate of 0.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 640.03M | 81.05% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definitive Healthcare | 635.16M |
| Entrada Therapeutics | 634.82M |
| Varex Imaging | 633.67M |
| Exscientia | 633.50M |
| EyePoint Pharmaceuticals | 628.28M |
| Oculis Holding AG | 625.40M |
| AnaptysBio | 618.01M |
| OrthoPediatrics | 617.51M |